US Patent

US8580830 — Non-mucoadhesive film dosage forms

Formulation · Assigned to APR Applied Pharma Research SA · Expires 2029-11-23 · 4y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects orally disintegrating film dosage forms for delivering active pharmaceutical agents, such as Zofran.

USPTO Abstract

Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the dosage forms for the treatment of various medical conditions are provided.

Drugs covered by this patent

Patent Metadata

Patent number
US8580830
Jurisdiction
US
Classification
Formulation
Expires
2029-11-23
Drug substance claim
No
Drug product claim
Yes
Assignee
APR Applied Pharma Research SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.